Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients.
Hoeh B, Flammia RS, Hohenhorst L, Sorce G, Chierigo F, Tian Z, Saad F, Gallucci M, Briganti A, Terrone C, Shariat SF, Graefen M, Tilki D, Kluth LA, Mandel P, Becker A, Chun FKH, Karakiewicz PI.
Hoeh B, et al. Among authors: chierigo f.
Prostate. 2022 May;82(6):687-694. doi: 10.1002/pros.24313. Epub 2022 Feb 21.
Prostate. 2022.
PMID: 35188982